Health ❯Healthcare

Obesity

Obesity Pharmaceuticals Patient Care Clinical Trials Medications Market Competition Public Health Weight Management Clinical Research Diabetes

Tirzepatide Outperforms Semaglutide in Weight-Loss Trial

The first head-to-head study confirms tirzepatide's superior efficacy, while semaglutide retains unique cardiovascular benefits.

GLP-1 Drugs Found to Cut Alcohol Consumption and Improve Mental Health

WHO to Endorse GLP-1 Weight-Loss Drugs, Calls for Global Access

Diabetes Drug Metformin Reduces Knee Pain in Osteoarthritis Patients, Study Finds

Novo Nordisk Seeks FDA Approval as Eli Lilly's Weight-Loss Pill Advances

Eli Lilly's Oral GLP-1 Pill Demonstrates Success in Phase 3 Trials

Eli Lilly's Mounjaro Launches in India, Targeting Obesity and Diabetes

Eli Lilly Launches Mounjaro in India to Address Obesity and Diabetes

Taxpayer-Funded Weight-Loss Drugs Face Scrutiny Over High Prices

Amgen Advances Weight-Loss Drug MariTide with Two Phase 3 Trials

Eli Lilly Expands Zepbound Access with New Doses and Lower Prices

UK Tightens Rules for Online Prescriptions of Weight-Loss Drugs

Poll Shows Americans Divided Over Weight-Loss Drugs for Obesity Treatment

Hims & Hers Debuts Super Bowl Ad Advocating for Affordable Weight-Loss Drugs

Allurion Technologies Stock Surges Following New Obesity Treatment Study Announcement

Novo Nordisk's Amycretin Shows 22% Weight Loss in Trial, Boosting Stock